Last March, the SARS-CoV-2 pandemic put mobility and social life on hold in most of the world, however in biotech and healthcare, things didn’t stop at all. It was just the opposite, in fact, with activity ramping up. But the pandemic has forced the sector to turn to new ways of working and, in some cases, seem they’re here to stay.
